OBI Pharma saw the highest growth of 299% in patent filings and 199% in grants in December in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 199% and grants by 49%. GlobalData’s DataBook provides a comprehensive analysis of OBI Pharma’s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

OBI Pharma has been focused on protecting inventions in Australia(AU) with two publications in Q4 2023

The Australia(AU) Patent Office dominates the patent filings and grants with nearly 12% filings and 25% grants. The Brazil(BR), Israel(IL), Australia(AU), and United States(US) patent Office are among the top ten patent offices where OBI Pharma is filings its patents. Among the top granted patent authorities, OBI Pharma has 50% of its grants in United States(US), 25% in Australia(AU) and 25% in Canada(CA).

Patents related to immuno-oncology and rare diseases lead OBI Pharma's portfolio

OBI Pharma has the highest number of patents in immuno-oncology followed by, rare diseases. For immuno-oncology, nearly 100% of patents were filed and no patents were granted in Q4 2023.

Breast cancer related patents lead OBI Pharma portfolio followed by carcinomas, and bladder carcinoma

OBI Pharma has highest number of patents in breast cancer followed by carcinomas, bladder carcinoma, nonmelanomatous skin cancer, and nasopharyngeal cancer.

For comprehensive analysis of OBI Pharma's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.